Scholarlink

Introduction <p>The rising prevalence of diabetes has driven extensive research into effective management strategies, emphasizing the importance of integrating self-management routines into daily life. This study presents real-world observations on the impact of the mySugr<sup>®</sup> app, used in conjunction with the Accu-Chek<sup>®</sup> Instant blood glucose monitoring device, on glycemic control and patient satisfaction in India.</p> Methods <p>This retrospective, observational, non-interventional study was conducted at 29 sites in India, involving people with diabetes (PwD) who used the mySugr<sup>®</sup> app in conjunction with the Accu-Chek<sup>®</sup> Instant glucose meter for at least 3&#xa0;months. Data from electronic health records and paper-based records were analyzed. The primary objective was to evaluate changes in glycated hemoglobin (HbA1c) levels over 3&#xa0;months. Additionally, the study assessed the frequency of hypoglycemic and hyperglycemic events, changes in HbA1c based on monitoring frequency, and the use of insulin and non-insulin therapies. Patient satisfaction with the mySugr<sup>®</sup> app was also assessed.</p> Results <p>A total of 111 PwD were included and had an average age of 53.2&#xa0;years. The mean HbA1c level significantly decreased from 8.8% to 7.5% (<i>p</i> &lt; 0.0001) in PwD using the mySugr<sup>®</sup> app in conjunction with the Accu-Chek<sup>®</sup> Instant glucose meter for at least 3&#xa0;months. Frequent monitoring (≥ 6 times per week) resulted in a greater HbA1c reduction (1.5%-points) compared to less frequent monitoring (1.0%-point). Insulin-treated PwD showed a larger HbA1c reduction (1.6%-points) compared to those not on insulin (0.8%-points). PwD reported an average of 1.9&#xa0;hypoglycemic and 20.0&#xa0;hyperglycemic events.</p> Conclusion <p>The mySugr<sup>®</sup> app, used in conjunction with the Accu-Chek<sup>®</sup> Instant glucose meter, demonstrated improved glycemic control. Future research should focus on larger, diverse samples and long-term evaluations to confirm these findings and explore the cost-effectiveness of integrating such applications into routine diabetes care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluating the Impact of mySugr® Mobile Health Application on Glycemic Control in People with Diabetes Mellitus in India: A Real-World Data Analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月17日

查看全文
  • V. Mohan,
  • Sanjay Kalra,
  • Abin Augustine,
  • Johanna Kober

摘要

Introduction

The rising prevalence of diabetes has driven extensive research into effective management strategies, emphasizing the importance of integrating self-management routines into daily life. This study presents real-world observations on the impact of the mySugr® app, used in conjunction with the Accu-Chek® Instant blood glucose monitoring device, on glycemic control and patient satisfaction in India.

Methods

This retrospective, observational, non-interventional study was conducted at 29 sites in India, involving people with diabetes (PwD) who used the mySugr® app in conjunction with the Accu-Chek® Instant glucose meter for at least 3 months. Data from electronic health records and paper-based records were analyzed. The primary objective was to evaluate changes in glycated hemoglobin (HbA1c) levels over 3 months. Additionally, the study assessed the frequency of hypoglycemic and hyperglycemic events, changes in HbA1c based on monitoring frequency, and the use of insulin and non-insulin therapies. Patient satisfaction with the mySugr® app was also assessed.

Results

A total of 111 PwD were included and had an average age of 53.2 years. The mean HbA1c level significantly decreased from 8.8% to 7.5% (p < 0.0001) in PwD using the mySugr® app in conjunction with the Accu-Chek® Instant glucose meter for at least 3 months. Frequent monitoring (≥ 6 times per week) resulted in a greater HbA1c reduction (1.5%-points) compared to less frequent monitoring (1.0%-point). Insulin-treated PwD showed a larger HbA1c reduction (1.6%-points) compared to those not on insulin (0.8%-points). PwD reported an average of 1.9 hypoglycemic and 20.0 hyperglycemic events.

Conclusion

The mySugr® app, used in conjunction with the Accu-Chek® Instant glucose meter, demonstrated improved glycemic control. Future research should focus on larger, diverse samples and long-term evaluations to confirm these findings and explore the cost-effectiveness of integrating such applications into routine diabetes care.